Loading organizations...
Loading organizations...
Innovative leader in biomarkers for immune-mediated inflammatory diseases.
IMIDomics has raised $16.5M across 1 funding round.
IMIDomics has raised $16.5M in total across 1 funding round.
IMIDomics has raised $16.5M in total across 1 funding round.
IMIDomics's investors include Michael Pucker, Bristol Myers Squibb, Tao Capital, The Pritzker Organization.
IMIDomics has raised $16.5M across 1 funding round. Most recently, it raised $16.5M Series A in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 27, 2021 | $16.5M Series A | Michael Pucker | Bristol Myers Squibb, Tao Capital, The Pritzker Organization |